Response to Neoadjuvant Chemotherapy Best Predicts Survival After Curative Resection of Gastric Cancer

Abstract

Response to neoadjuvant chemotherapy is the single most important predictor of overall survival after neoadjuvant chemotherapy for gastric cancer. These findings support further evaluation of neoadjuvant approaches in the treatment of this disease.